Amitriptyline & Migraines

Amitriptyline is a tricyclic antidepressant that has been used for migraine prevention for decades. At the low doses used for migraines (much lower than antidepressant doses), it works by increasing levels of serotonin and norepinephrine in the brain. These neurotransmitters play important roles in pain modulation.

Amitriptyline also blocks certain sodium channels and histamine receptors, which may contribute to its pain-preventing effects. It appears to reduce the excitability of neurons involved in migraine initiation and lower the brain's sensitivity to triggers. Its sedating properties can be a side effect or a benefit, depending on whether sleep problems are part of your migraine picture.

For migraine prevention, amitriptyline is typically started at 10 mg taken at bedtime. The dose is gradually increased over weeks, with most people finding their effective dose between 10-50 mg. This is significantly lower than the 150-300 mg doses used for depression, which means the side effect burden is usually lighter.

Taking it at bedtime takes advantage of its sedating effects, helping with sleep while reducing next-day drowsiness. Like other preventive medications, it takes time to work. You should expect to wait four to six weeks at your target dose before seeing the full benefit. Your doctor will work with you to find the lowest effective dose.

The most common side effects at low doses include drowsiness, dry mouth, constipation, weight gain, and morning grogginess. Drowsiness is often most pronounced in the first week or two and tends to improve as your body adjusts. Weight gain is a longer-term concern that affects some people.

Amitriptyline can cause dizziness when standing up quickly due to blood pressure changes. It should be used cautiously in older adults and people with heart rhythm problems. Stopping it abruptly is not recommended, as this can cause withdrawal symptoms. If you need to discontinue, your doctor will taper the dose gradually.

Amitriptyline is one of the best-studied migraine preventives. Research consistently shows it reduces migraine frequency by 40-50% in many patients. It's particularly valued for people who also deal with tension-type headaches, insomnia, or depression alongside their migraines, since it can address multiple conditions simultaneously.

Head-to-head studies have shown amitriptyline to be comparable in effectiveness to propranolol and topiramate. Some research suggests it may be especially effective for people with chronic daily headache or mixed headache types. Its long track record, low cost, and ability to address comorbid conditions make it a popular first-line choice.

Starting a preventive like amitriptyline is a commitment that requires patience. Tracking your migraines consistently before and after starting gives you objective data about whether it's working. Without tracking, it's surprisingly easy to overestimate or underestimate your improvement.

With CalmGrid, you can compare month-over-month attack frequency, severity, and how well your acute medications work. Some people also notice improvements in sleep quality and overall headache burden that aren't captured by simply counting migraine days. Sharing this comprehensive picture with your doctor leads to better decisions about whether to continue, adjust, or switch treatments.